| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Phreesia, Inc.'s insiders have reduced their positions by a net 536 shares worth roughly $6K. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. PHR sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.39M | $17.38M | - | |
| Pres | 842.5K | $10.54M | - | |
| Pres | 224.1K | $2.80M | - | |
| VP | 168.9K | $2.11M | - | |
| Other | 163.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 | Linetsky David71 | SVP, Life Sciences | Sell | 130 | $19.67 | $2,556.52 | -0.5% | +18.0% | +25.0% | |
| Sep 14, 2023 | Vanduyn Amy Beth66 | SVP, Human Resources | Sell | 3,826 | $20.24 | $77,455.08 | -1.1% | +4.7% | +22.9% | |
| Sep 14, 2023 | Davidoff Michael J.65 | SVP, Payer Business | Sell | 6,559 | $20.26 | $132,880.01 | -2.2% | +4.7% | +22.9% | |
| Sep 14, 2023 | Hoffman Allison C66 | General Counsel &Secretary | Sell | 5,466 | $20.27 | $110,790.08 | -1.5% | +4.7% | +22.9% | |
| Sep 13, 2023 | Roberts Evan72 | Chief Operating Officer | Sell | 3,907 | $20.34 | $79,464.86 | -0.3% | -0.9% | +17.7% | |
| Sep 13, 2023 | Gunzburg Janet50 | Principal Accounting Officer | Sell | 934 | $20.34 | $18,996.45 | -1.1% | -0.9% | +17.7% | |
| Sep 13, 2023 | Gandhi Balaji70 | Chief Financial Officer | Sell | 3,957 | $20.34 | $80,481.82 | -2.2% | -0.9% | +17.7% | |
| Sep 13, 2023 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 2,178 | $20.34 | $44,298.59 | -0.5% | -0.9% | +17.7% | |
| Sep 13, 2023 | Indig Chaim71 | Chief Executive Officer | Sell | 6,555 | $20.34 | $133,323.04 | -0.3% | -0.9% | +17.7% | |
| Jul 21, 2023 | Davidoff Michael J.65 | SVP, Payer Business | Sell | 1,075 | $31.75 | $34,131.25 | -1.1% | -49.2% | -26.2% |